ArticleProceedings of the National Academy of Sciences of the United States of America2017

Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease.

Elizaveta S Leshchiner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.